Vicapsys Life Sciences, Inc.
VICP · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $31 | $31 |
| Gross Profit | $0 | $0 | -$31 | -$31 |
| % Margin | – | – | – | – |
| R&D Expenses | $14 | $15 | $13 | $18 |
| G&A Expenses | $0 | $769 | $509 | $319 |
| SG&A Expenses | $800 | $769 | $631 | $319 |
| Sales & Mktg Exp. | $0 | $0 | $122 | $0 |
| Other Operating Expenses | $0 | $263 | $0 | $0 |
| Operating Expenses | $814 | $1,047 | $645 | $337 |
| Operating Income | -$814 | -$1,047 | -$985 | -$337 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$176 | -$135 | -$340 | $100 |
| Pre-Tax Income | -$990 | -$1,182 | -$985 | -$237 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$990 | -$1,182 | -$985 | -$237 |
| % Margin | – | – | – | – |
| EPS | -0.029 | -0.034 | -0.032 | -0.013 |
| % Growth | 15.8% | -5.9% | -141% | – |
| EPS Diluted | -0.029 | -0.034 | -0.032 | -0.013 |
| Weighted Avg Shares Out | 34,328 | 34,549 | 30,578 | 17,657 |
| Weighted Avg Shares Out Dil | 34,328 | 34,549 | 30,578 | 17,657 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $90 | $135 | $0 | $0 |
| Depreciation & Amortization | $0 | $31 | $31 | $31 |
| EBITDA | -$900 | -$1,016 | -$613 | -$306 |
| % Margin | – | – | – | – |